Allopregnanolone

University of Arizona Receives $37.5M NIH Grant to Research Potential Regenerative Therapy for Alzheimer’s Disease

Sep 8, 2019 | Allopregnanolone, Alzheimer's Disease, Regenerative Medicine, Stem Cell

The University of Arizona Center for Innovation in Brain Science just received $37.5 million from the National Institutes of Health (NIH) for research into prospective regenerative therapy for Alzheimer’s disease. A Phase II clinical trial will be used to determine...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

University of Arizona Receives $37.5M NIH Grant to Research Potential Regenerative Therapy for Alzheimer’s Disease

Pin It on Pinterest